Patents by Inventor Michael AARON

Michael AARON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10908366
    Abstract: Aspects and techniques of the present disclosure relate to an alignment device that includes a groove-type alignment structure with a support region for receiving an optical fiber inserted along a fiber insertion axis. The optical fiber has a first side and a second, opposite side. The groove-type alignment structure engages the first side of the optical fiber. The alignment device includes a stabilization structure that engages the first side of the optical fiber and a first angled transition surface that engages the second, opposite side of the optical fiber. The present disclosure also relates to an alignment system that includes a first housing piece; a second housing piece adapted to mate with the first housing piece; and a flat structure positioned between the first and second housing pieces.
    Type: Grant
    Filed: December 5, 2017
    Date of Patent: February 2, 2021
    Assignee: CommScope Technologies LLC
    Inventors: Steven C. Zimmel, Michael James Ott, Danny Willy August Verheyden, Michael Aaron Kadar-Kallen, Gary William Adams, Robert Charles Flaig, Gregory J. Schaible
  • Publication number: 20210024497
    Abstract: The present invention provides, in part, compounds of Formula I: or an N-oxide thereof, or a pharmaceutically acceptable salt of the compound or the N-oxide, wherein: X1, X2, R1, R2, m and n are as described herein; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds, N-oxides, or salts, and their uses for treating M4-mediated (or M4-associated) disorders including, e.g., Alzheimer's Disease, Parkinson's Disease, schizophrenia (e.g., its cognitive and negative symptoms), pain, addiction, and a sleep disorder.
    Type: Application
    Filed: March 25, 2019
    Publication date: January 28, 2021
    Inventors: Lei Zhang, Erik Alphie LaChapelle, Christopher Ryan Butler, Natasha Mariam Kablaoui, Michael Aaron Brodney, Laura Ann McAllister, Qingyi Yang, Christopher John Helal, Damien Webb
  • Publication number: 20210026077
    Abstract: A portable device for attaching a connector to an optical fiber, the optical fiber having an end, the device comprising means for receiving the optical fiber at the end of the optical fiber; and a connector station for autonomously attaching the connector to the optical fiber.
    Type: Application
    Filed: September 28, 2020
    Publication date: January 28, 2021
    Applicants: CommScope Connectivity Belgium BVBA, CommScope Technologies LLC
    Inventors: Danny Willy August VERHEYDEN, David Donald ERDMAN, Michael GURRERI, Randall Bobby PAUL, Jan WATTÉ, Robert Charles FLAIG, Alan Edward PLOTTS, Michael Aaron KADAR-KALLEN, Shelly Ann BUCHTER, Jan VANDENBROECK, Patrick BILLET, Stefano BERI, André Johannes Maria HILDERINK, Hernes JACOBS, Petrus Theodorus RUTGERS, Petrus Theodorus KRECHTING, Martijn Johannes WOLBERS, Walter MATTHEUS, Cristian-Radu RADULESCU, Paul VITS, Karel Johannes VAN ASSENBERGH, Pieter Cornelis Johan DE JAGER, Henk Jan Theodoor VAN DER POL
  • Patent number: 10888407
    Abstract: A composite implant device for use in a medical application, comprising a synthetically-derived mesh that mimics particular critical aspects of a biologically-derived mesh. The composite implant device can be used for the reinforcement and reconstruction of tissues within the body and can be comprised of a majority of synthetic components and minority of naturally-derived components which mimic the structure and function of a naturally-derived mesh.
    Type: Grant
    Filed: December 10, 2016
    Date of Patent: January 12, 2021
    Assignee: POLY-MED, INC.
    Inventors: Seth Dylan McCullen, Clayton Joseph Culbreath, Michael Aaron Vaughn, Michael Scott Taylor
  • Patent number: 10871616
    Abstract: A system for connecting a fiber optic connector to a fiber optic adapter includes various alternative improvements, including improvements to the shutter, the alignment device, and the adapter in general.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: December 22, 2020
    Assignee: CommScope Technologies LLC
    Inventors: Michael Aaron Kadar-Kallen, Michael Ward Zitsch, Dwight Andrew Bretz, Michael James Ott, Robert Charles Flaig
  • Patent number: 10858373
    Abstract: The present invention provides, in part, heterocyclic spiro compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating MAGL-mediated diseases and disorders including, e.g., pain, an inflammatory disorder, depression, anxiety, Alzheimer's disease, a metabolic disorder, stroke, or cancer.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: December 8, 2020
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Laura Ann McAllister, Christopher John Helal, Steven Victor O'Neil, Patrick Robert Verhoest
  • Publication number: 20200369565
    Abstract: An insulated glass unit is described and includes at least a first glass layer, a second glass layer and a third glass layer disposed therebetween. The third glass layer is separated from the first glass layer and the second glass layer by first and second sealed gap spaces. The third glass layer has a low CTE as compared to the CTE of the first and/or second glass layers. In some instances, the third glass layer has a CTE of less than 70×10?7/° C. over a temperature range of 0-300° C.
    Type: Application
    Filed: December 20, 2018
    Publication date: November 26, 2020
    Inventors: Thomas Bertin-Mourot, James Gregory Couillard, Michael Aaron McDonald
  • Publication number: 20200361939
    Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.
    Type: Application
    Filed: May 13, 2020
    Publication date: November 19, 2020
    Inventors: Upul Keerthi BANDARAGE, Cavan McKeon BLIGH, Diane BOUCHER, Michael John BOYD, Michael Aaron BRODNEY, Michael Philip CLARK, Veronique DAMAGNEZ, Lev Tyler Dewey FANNING, Robert Francis FIMOGNARI, Gabrielle Simone FLEMING, Kevin James GAGNON, Pedro Manuel GARCIA BARRANTES, Robert Daniel GIACOMETTI, Simon GIROUX, Ronald Lee GREY, Jr., Samantha GUIDO, Amy Beth HALL, Sarah Carol HOOD, Dennis James HURLEY, Mac Arthur JOHNSON, Jr., Peter Jones, Sarathy KESAVAN, Mei-Hsiu LAI, Siying LIU, Adam LOOKER, Brad MAXWELL, John Patrick MAXWELL, Ales MEDEK, Philippe Marcel NUHANT, Kirk Alan OVERHOFF, Setu RODAY, Stefanie ROEPER, Steven M. RONKIN, Rupa SAWANT, Yi SHI, Muna SHRESTHA, Marisa SPOSATO, Kathy STAVROPOULOS, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Qing TANG, Stephen THOMSON, Jinwang XU, Mariam ZAKY
  • Patent number: 10832506
    Abstract: An encrypted security system and associated methods for controlling physical access are described. The system includes a security server configured to receive a request for authentication from a mobile device, the request including information identifying the mobile device and a physical access control device. The security server forwards an encryption message including a plurality of unique identifiers to the physical access control device via the mobile device. The physical access control device is configured to authenticate the plurality of unique identifiers in the encryption message and operate an access control mechanism.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: November 10, 2020
    Assignee: Delphian Systems, LLC
    Inventors: Gary L. Myers, Ashok Hirpara, John D. Veleris, Arkadiusz Zimny, Michael Aaron Cohen, Eugene Nakshin
  • Publication number: 20200319412
    Abstract: A fiber optic adapter includes an adapter body defining a port leading to an alignment structure. The optical adapter also defines a platform disposed at the first port. The platform is recessed inwardly from an outer periphery of the adapter body. The platform includes latching members having catch surfaces. A fiber optic connector includes a connector plug body holding an optical fiber. The connector also includes a latching arm having a latching end that defines two rearwardly facing catch surfaces separated by a central webbing, which extends along a length of the latching arm. The rearwardly facing catch surfaces align with the catch surfaces of the latching members when the fiber optic connector is received at the fiber optic adapter.
    Type: Application
    Filed: April 20, 2020
    Publication date: October 8, 2020
    Applicant: COMMSCOPE TECHNOLOGIES LLC
    Inventors: Michael Aaron KADAR-KALLEN, Robert Charles FLAIG, Danny Willy August VERHEYDEN
  • Patent number: 10798847
    Abstract: In one aspect, an apparatus comprises a first housing and a second housing. The first housing comprises a surface to receive heat from a heat-generating component. The second housing comprising a receptacle in which to receive the first housing. The first housing is to nest within the receptacle. The receptacle inhibits movement of the first housing along a first axis and facilitates movement of the first housing along a second axis. The first housing is moveable within the receptacle along the second axis. Movement of the first housing along the second axis changes a size of a gap between the surface and the heat-generating component.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: October 6, 2020
    Assignee: Intel Corporation
    Inventors: Michael Aaron Schroeder, Erich Nolan Ewy
  • Publication number: 20200312072
    Abstract: An encrypted security system and associated methods for controlling physical access are described. The system includes a security server configured to receive a request for authentication from a mobile device, the request including information identifying the mobile device and a physical access control device. The security server forwards an encryption message including a plurality of unique identifiers to the physical access control device via the mobile device. The physical access control device is configured to authenticate the plurality of unique identifiers in the encryption message and operate an access control mechanism.
    Type: Application
    Filed: March 11, 2020
    Publication date: October 1, 2020
    Applicant: Delphian Systems, LLC
    Inventors: Gary L Myers, Ashok Hirpara, John D. Veleris, Arkadiusz Zimny, Michael Aaron Cohen, Eugene Nakshin
  • Patent number: 10788625
    Abstract: A portable device for attaching a connector to an optical fiber, the optical fiber having an end, the device comprising means for receiving the optical fiber at the end of the optical fiber; and a connector station for autonomously attaching the connector to the optical fiber.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: September 29, 2020
    Assignees: CommScope Connectivity Belgium BVBA, CommScope Technologies LLC
    Inventors: Danny Willy August Verheyden, David Donald Erdman, Michael Gurreri, Randall Bobby Paul, Jan Watté, Robert Charles Flaig, Alan Edward Plotts, Michael Aaron Kadar-Kallen, Shelly Ann Buchter, Jan Vandenbroeck, Patrick Billet, Stefano Beri, André Johannes Maria Hilderink, Hernes Jacobs, Petrus Theodorus Rutgers, Petrus Theodorus Krechting, Martijn Johannes Wolbers, Walter Mattheus, Cristian-Radu Radulescu, Paul Vits, Karel Johannes Van Assenbergh, Pieter Cornelis Johan De Jager, Henk Jan Theodoor Van Der Pol
  • Publication number: 20200294340
    Abstract: An encrypted security system and associated methods for controlling physical access. The system includes a security server configured to receive a request for authentication from a mobile device, the request comprising information identifying the mobile device and a physical access control device. The security server forwards an encryption message comprising a plurality of unique identifiers to the physical access control device via the mobile device. The physical access control device is configured to authenticate the plurality of unique identifiers in the encryption message and operate an access control mechanism.
    Type: Application
    Filed: March 11, 2020
    Publication date: September 17, 2020
    Applicant: Delphian Systems, LLC
    Inventors: Gary L. Myers, Ashok Hipara, John D. Veleris, Michael Aaron Cohen, Eugene Nashkin, Arkadiusz Zinny
  • Publication number: 20200283407
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), Parkinson's disease and chronic apathy.
    Type: Application
    Filed: May 21, 2020
    Publication date: September 10, 2020
    Inventors: Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green, Jaclyn Louise Henderson, Chewah Lee, Scot Richard Mente, Steven Victor O'Neil, Bruce Nelsen Rogers, Lei Zhang
  • Publication number: 20200268893
    Abstract: In situ gel-forming compositions are disclosed, which may comprise one or more absorbable polymers, solvents such as N-methyl-2-pyrrolidone, polyethylene glycol or DMSO, and one or more bioactive agents. The composition forms a hydrogel or semi-solid mass on contact with an aqueous environment. Methods of using in situ gel-forming composition for various applications are also disclosed.
    Type: Application
    Filed: June 29, 2018
    Publication date: August 27, 2020
    Inventors: David Ingram, Michael Aaron Vaughn, Michael Scott Taylor, Kara Bethany Acampora, David Gravett
  • Publication number: 20200262833
    Abstract: The present invention provides, in part, compounds of Formula I, or an N-oxide thereof, or a pharmaceutically acceptable salt of the compound or the N-oxide, wherein: (R1)a, (R2)b, (R3)c, L, A, and E are as described herein; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds, N-oxides, or salts, and their uses for treating M4-mediated (or M4-associated) disorders including, e.g., Alzheimer's Disease, schizophrenia (e.g., its cognitive and negative symptoms), pain, addiction, and a sleep disorder.
    Type: Application
    Filed: June 14, 2018
    Publication date: August 20, 2020
    Inventors: Elizabeth Mary Beck, Michael Aaron Brodney, Matthew Frank Brown, Christopher Ryan Butler, Adam Matthew Gilbert, Erik Alphie Lachapelle, Laura Ann McAllister, Daniel Paul Uccello, Lei Zhang
  • Patent number: 10723711
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating MAGL-mediated diseases and disorders including, e.g., pain, an inflammatory disorder, traumatic brain injury, depression, anxiety, Alzheimer's disease, a metabolic disorder, stroke, or cancer.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: July 28, 2020
    Assignee: Pfizer Inc.
    Inventors: Christopher Ryan Butler, Laura Ann McAllister, Elizabeth Mary Beck, Michael Aaron Brodney, Adam Matthew Gilbert, Christopher John Helal, Douglas Scott Johnson, Justin Ian Montgomery, Steven Victor O'Neil, Bruce Nelsen Rogers, Patrick Robert Verhoest, Damien Webb
  • Publication number: 20200207762
    Abstract: The present invention provides, in part, compounds of Formula I: or an N-oxide thereof, or a pharmaceutically acceptable salt of the compound or the N-oxide, wherein: R1, R2, L, A, and E are as described herein; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds, N-oxides, or salts, and their uses for treating M4-mediated (or M4-associated) disorders including, e.g., Alzheimer's Disease, schizophrenia (e.g., its cognitive and negative symptoms), pain, addiction, and a sleep disorder.
    Type: Application
    Filed: February 21, 2020
    Publication date: July 2, 2020
    Inventors: Lei Zhang, Christopher Ryan Butler, Elizabeth Mary Beck, Michael Aaron Brodney, Matthew Frank Brown, Laura Ann McAllister, Erik Alphie LaChapelle, Adam Matthew Gilbert
  • Patent number: D900125
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: October 27, 2020
    Assignee: United Services Automobile Association (USAA)
    Inventors: Michael Aaron McGlasson, Stephen Holloway, Lea B. Sims, Richard R. Rohrbough, Paul LaFleur, Emily Eaton, Joseph Wall, Nathan J. Rowe, Gualberto Camacho, Melisa Izaguirre